Pipeline

ImmuPharma is a biopharmaceutical company that specialises in the usage and development of biopolymers, specifically peptides.

Our late-stage to preclinical pipeline is focused on two core therapeutic areas; autoimmunity & inflammation and anti-infectives.

Lupuzor™ Lupus
P140 CIDP*
P140 other indications

*Phase 2/3 adaptive trial becomes a pivotal trial for filing

BioAMB Fungal infections
BioCIN Bacterial infections

Our core therapeutic areas

Autoimmunity &
Inflammation

The P140 platform
LUPUZORTM for Lupus
P140 for CIDP

Anti-infectives

BioAMB
for systemic fungal infections
BioCIN
for severe bacterial infections

Key progress

All announcements
Our science
ImmuPharma Biotech